Viewing Study NCT01915602

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 3:45 AM

Ignite Modification Date: 2025-12-26 @ 2:32 AM

Study NCT ID: NCT01915602

Status: COMPLETED

Last Update Posted: 2021-04-08

First Post: 2013-07-24

Is NOT Gene Therapy: False

Has Adverse Events: False

Brief Title: Refametinib in Combination With Sorafenib in RAS Mutant Hepatocellular Carcinoma (HCC)

Sponsor: Bayer

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module